Table of contents
December 2005 Vol 4 No 12
In this issue
p941 | doi:10.1038/nrd1922
Editorial: What shoulder and what art
p943 | doi:10.1038/nrd1923
News and Analysis
Star role for bacteria in controlling flu pandemic? | PDF (350 KB)
p945 | doi:10.1038/nrd1917
First phase of HapMap project already helping drug discovery | PDF (134 KB)
p947 | doi:10.1038/nrd1918
News in Brief
Patent watch
ESTs must pass specific and substantial utility test | PDF (59 KB)
p950 | doi:10.1038/nrd1920
Patent watch
Can making a correlation be patented? | PDF (72 KB)
p950 | doi:10.1038/nrd1921
Patent primer
Medical treatment inventions | PDF (58 KB)
p951 | doi:10.1038/nrd1908
An Audience With
Fred Hassan | PDF (64 KB)
p952 | doi:10.1038/nrd1915
From the analyst's couch
Authorized Generics | PDF (242 KB)
p953 | doi:10.1038/nrd1906
Fresh from the Pipeline
Tipranavir | PDF (146 KB)
p955 | doi:10.1038/nrd1907
Career focus
Assay development: an increasingly creative endeavour | PDF (53 KB)
p956 | doi:10.1038/nrd1916
Research Highlights
Antibacterial drugs: Peptide power | PDF (127 KB)
p957 | doi:10.1038/nrd1910
Regeneration: A new stop signal | PDF (241 KB)
p958 | doi:10.1038/nrd1911
Inflammatory disease: Local therapy for inflammatory bowel disease | PDF (459 KB)
p958 | doi:10.1038/nrd1912
Computational chemistry: Ready, steady, screen! | PDF (281 KB)
p959 | doi:10.1038/nrd1913
Ion channels: Stopping the flow | PDF (140 KB)
p960 | doi:10.1038/nrd1909
In brief
Drug metabolism | HIV | Cardiotoxicity | Infectious diseases | PDF (140 KB)
p960 | doi:10.1038/nrd1914
Perspectives
Innovation
Rescuing drug discovery: in vivo systems pathology and systems pharmacology
Jan van der Greef & Robert N. McBurney
p961 | doi:10.1038/nrd1904
Opinion
NK3 receptor antagonists: the next generation of antipsychotics?
Will Spooren, Claus Riemer & Herbert Meltzer
p967 | doi:10.1038/nrd1905
Reviews
Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms
Mukesh K. Jain & Paul M. Ridker
p977 | doi:10.1038/nrd1901
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
Bryan T. Hennessy, Debra L. Smith, Prahlad T. Ram, Yiling Lu & Gordon B. Mills
p988 | doi:10.1038/nrd1902
Finding New Tricks For Old Drugs: An Efficient Route For Public-Sector Drug Discovery
Kerry A. O'Connor & Bryan L. Roth
p1005 | doi:10.1038/nrd1900
NAAG peptidase inhibitors and their potential for diagnosis and therapy
Jia Zhou, Joseph H. Neale, Martin G. Pomper & Alan P. Kozikowski
p1015 | doi:10.1038/nrd1903
Correction: Opportunities in somatostatin research: biological, chemical and therapeutic aspects
Gisbert Weckbecker , Ian Lewis , Rainer Albert , Herbert A. Schmid , Daniel Hoyer & Christian Bruns
| doi:10.1038/nrd1924
Correction: Animal rights extremism crosses the Atlantic
Stuart Blackman
| doi:10.1038/nrd1925
